Rheumatology International

Papers
(The TQCC of Rheumatology International is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review292
Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management212
SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis114
Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey91
ANCA-associated vasculitis after COVID-1985
Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment84
Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic77
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study77
Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes75
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly71
Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews69
YouTube as a source of information on gout: a quality analysis68
COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey67
Kawasaki-like disease in children with COVID-1963
The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey62
Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review61
The Beighton Score as a measure of generalised joint hypermobility61
Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease—a randomised controlled trial60
Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey58
Comorbidities in psoriatic arthritis: a systematic review and meta-analysis56
Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands53
Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic53
Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis52
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry50
Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent47
COVID-19 pandemic in Japan46
Reactive arthritis after COVID-19: a case-based review45
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review43
Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic41
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis40
Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study37
The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk37
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol36
Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural–urban gap and north–south gradient35
Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic34
Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes32
Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-1932
Implications of COVID-19 in pediatric rheumatology32
Immune checkpoint inhibitor-induced musculoskeletal manifestations31
Sex hormones, autoimmunity and gender disparity in COVID-1931
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates31
Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting31
The prevalence of fibromyalgia in axial spondyloarthritis28
Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)28
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study28
Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development28
Comorbidities and phenotype–genotype correlation in children with familial Mediterranean fever26
Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination25
Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-1925
Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound25
Rheumatologists’ practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt25
Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: evidence from Google Trends25
Macrophage activation syndrome in adult dermatomyositis: a case-based review24
Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging24
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review24
Statistical data presentation: a primer for rheumatology researchers23
Are patients with hypermobile Ehlers–Danlos syndrome or hypermobility spectrum disorder so different?22
Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease22
Corticosteroid monotherapy for the management of Takayasu arteritis—a systematic review and meta-analysis22
The incidence and prevalence of cardiovascular diseases in gout: a systematic review and meta-analysis22
Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities20
Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review20
Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions20
Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection20
Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs20
Measurement of sedentary time and physical activity in rheumatoid arthritis: an ActiGraph and activPAL™ validation study19
Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients19
Post-publication promotion in rheumatology: a survey focusing on social media19
Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–201719
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt19
Prevalence of osteoarthritis in lower middle- and low-income countries: a systematic review and meta-analysis19
Publication activity in the field of Sjögren’s syndrome: a ten-year Web of Science based analysis19
Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases18
Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: case-based review18
Scholarly publishing and journal targeting in the time of the Coronavirus Disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists18
Patients’ beliefs and behaviours are associated with perceptions of safety and concerns in a hypothetical biosimilar switch18
Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review17
Treatment of refractory adult onset Still’s disease with tocilizumab—a single centre experience and literature review17
YouTube videos as a source of information concerning Behçet’s disease: a reliability and quality analysis17
The effectiveness and safety of electrotherapy in the management of fibromyalgia17
Granulomatous mastitis, erythema nodosum and arthritis syndrome: case-based review17
Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as potential makers for digital ulcers and interstitial lung disease in patients with systemic sclerosis: cross-sectional analysis of da17
Pain is not the major determinant of quality of life in fibromyalgia: results from a retrospective “real world” data analysis of fibromyalgia patients17
A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient17
The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis17
Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study17
Osteitis condensans ilii: current knowledge and diagnostic approach17
Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database17
YouTube as a source of information on COVID-19 vaccination in rheumatic diseases16
The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study16
Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America16
Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry16
Ankylosing spondylitis rehabilitation publications and the global productivity: a Web of Science-based bibliometric analysis (2000–2019)16
Contribution of Arab Countries to Familial Mediterranean Fever Research: a PubMed-based bibliometric analysis15
The relationship between cervical proprioception and balance in patients with fibromyalgia syndrome15
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort15
Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study15
Expanding the spectrum of reactive arthritis (ReA): classic ReA and infection-related arthritis including poststreptococcal ReA, Poncet’s disease, and iBCG-induced ReA14
Why do some people with severe chronic pain adhere to walking prescriptions whilst others won’t? A cross-sectional study exploring clinical and psychosocial predictors in women with fibromyalgia14
The importance of heart and brain imaging in children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C)14
Epidemiology and genetics of granulomatosis with polyangiitis14
The influence of perioperative interventions targeting psychological distress on clinical outcome after total knee arthroplasty14
Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study14
Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population13
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry13
Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine13
The feasibility of an exercise intervention to improve sleep (time, quality and disturbance) in people with rheumatoid arthritis: a pilot RCT13
Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study13
#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic13
Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective13
Patient self-sampling: a cornerstone of future rheumatology care?13
Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis13
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed13
0.038397073745728